Robot-assisted partial nephrectomy: 7-year outcomes.

Journal: Minerva urology and nephrology
Published Date:

Abstract

BACKGROUND: The role of robot-assisted partial nephrectomy (RAPN) in the management of renal masses has exponentially grown over the past 10 years. Nevertheless, data on long term outcomes of the procedure remains limited. Herein we report oncological and functional outcomes of patients who underwent RAPN for a malignant mass with a median follow-up of 7 years, the longest follow-up to date.

Authors

  • Umberto Carbonara
    Division of Urology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA; Department of Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy.
  • Giuseppe Simone
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Fabio Crocerossa
    Division of Urology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Alessandro Veccia
    Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Samuel Weprin
    Division of Urology, VCU Health System, Richmond, Virginia.
  • Pasquale Ditonno
    Urology and Andrology Unit II, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
  • Aldo Brassetti
    Fondazione Vincenzo Pansadoro, Centro di Urologia Laparoscopica e Oncologia Medica, Rome, Italy. Electronic address: aldo.brassetti@gmail.com.
  • Alfredo Bove
    Department of Urology, Regina Elena Institute, Rome, Italy.
  • Andrea Mari
  • Antonio Andrea Grosso
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Marco Carini
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Lance J Hampton
    Division of Urology, Department of Surgery, VCU Health System, Richmond, VA.
  • Michele Gallucci
    Department of Urology, La Sapienza University, Rome, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Riccardo Autorino
    Department of Urology, Rush University, Chicago, IL, USA.